Focalin Capsule, Extended Release
Pricing Report NDC 0078-0493-05

Current NADAC: $4.91461 per EA · Effective Aug 19, 2026 · Est. package price $491.46 (100 EA)
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

The current wholesale acquisition cost for Focalin Xr (NDC 0078-0493-05) is $4.91461 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Aug 19, 2026.

As a a human prescription drug provided by Novartis Pharmaceuticals Corporation, this medication is distributed in a 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$4.91461
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Aug 19, 2026
Billable Units
100 EA
Estimated Package Price
$491.46
Data Status
As of Sep 02, 2026
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
B - Brand
Package NDC
0078-0493-05
Description
100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
Generic Benchmark
The generic equivalent rate is $0.83291 (Effective: Aug 19, 2026)
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Jul 2013, the NADAC wholesale price for (NDC ) has moved within a range of $4.90454 to $13.58201 per EA. Over this 13 years and 1 month period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$4.9045 - $13.5820
Market Volatility
176.93% Variance
Latest Trend
0.02%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Aug 19, 2026 $4.91461 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jul 22, 2026 $4.91339 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jun 17, 2026 $4.91667 EAC/I - Chain or Independent PharmacyCode 1B - Brand
May 20, 2026 $4.91538 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Apr 22, 2026 $4.91718 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Mar 18, 2026 $4.91344 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Feb 18, 2026 $4.91338 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jan 21, 2026 $4.91348 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Dec 17, 2025 $4.91398 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Nov 19, 2025 $4.91264 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Oct 22, 2025 $4.91119 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Sep 17, 2025 $4.91635 EAC/I - Chain or Independent PharmacyCode 1B - Brand

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: September 09, 2026